-
Mashup Score: 8IASLC Global Member Survey on Inclusivity | IASLC - 19 hour(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7IASLC Global Member Survey on Inclusivity | IASLC - 4 day(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11
Dr. Narjust Florez, Lung Cancer Considered Host, encourages members to participate in the first IASLC Global Membership Survey on Inclusivity. The 5-minute survey, is available in multiple languages and aims to understand the unique needs of each of our regions and those members. The data collected will be used to improve the organization’s diversity, equity, and inclusion efforts.
Source: voicesoftheiaslc.gv-one.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9
Dr. Narjust Florez, Lung Cancer Considered Host, encourages members to participate in the first IASLC Global Membership Survey on Inclusivity. The 5-minute survey, is available in multiple languages and aims to understand the unique needs of each of our regions and those members. The data collected will be used to improve the organization’s diversity, equity, and inclusion efforts.
Source: voicesoftheiaslc.gv-one.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 15Annual Report 2023 | IASLC - 23 day(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 13
The goal of surgical resection is to completely remove a cancer; it is useful to have a system to describe how well this was accomplished. This is captured by the residual tumor (R) classification, which is separate from the TNM classification that describes the anatomic extent of a cancer independent of treatment. The traditional R-classification designates as R0 a complete resection, as R1 a macroscopically complete resection but with microscopic tumor at the surgical margin, and as R2 a resection that leaves gross tumor behind.
Source: www.jto.orgCategories: General Medicine News, Onc News and JournalsTweet-
This paper represents a comprehensive review of evidence regarding R categories & the descriptors thereof. W/the same overall framework & descriptors in the 9th edition, refinements to the descriptors should facilitate application & further research.https://t.co/Pqc8zM7djK #IASLC https://t.co/M8MHFkSSq3
-
-
Mashup Score: 60
Biomarker testing is essential in lung cancer care, allowing for personalized diagnosis and treatment. Survey closes March 23, 2024.
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet-
Today, the #IASLC released its Global Survey on Biomarker Testing. To discuss the importance of this survey & its underlying issues, @StephenVLiu discusses some of the barriers to biomarker testing w/@DeboraBrunoMD1, @RManochakian & @MattSmeltzer. Listen: https://t.co/RudbaZPY2B https://t.co/MP3eUdSnmy
-
-
Mashup Score: 60
Biomarker testing is essential in lung cancer care, allowing for personalized diagnosis and treatment. Survey closes March 23, 2024.
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet-
Today, the #IASLC released its Global Survey on Biomarker Testing. To discuss the importance of this survey & its underlying issues, @StephenVLiu discusses some of the barriers to biomarker testing w/@DeboraBrunoMD1, @RManochakian & @MattSmeltzer. Listen: https://t.co/RudbaZPY2B https://t.co/MP3eUdSnmy
-
-
Mashup Score: 60
Biomarker testing is essential in lung cancer care, allowing for personalized diagnosis and treatment. Survey closes March 23, 2024.
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet-
Today, the #IASLC released its Global Survey on Biomarker Testing. To discuss the importance of this survey & its underlying issues, @StephenVLiu discusses some of the barriers to biomarker testing w/@DeboraBrunoMD1, @RManochakian & @MattSmeltzer. Listen: https://t.co/RudbaZPY2B https://t.co/MP3eUdSnmy
-
-
Mashup Score: 60
Biomarker testing is essential in lung cancer care, allowing for personalized diagnosis and treatment. Survey closes March 23, 2024.
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet-
Today, the #IASLC released its Global Survey on Biomarker Testing. To discuss the importance of this survey & its underlying issues, @StephenVLiu discusses some of the barriers to biomarker testing w/@DeboraBrunoMD1, @RManochakian & @MattSmeltzer. Listen: https://t.co/RudbaZPY2B https://t.co/MP3eUdSnmy
-
Your Perspective Matters! Your Impact Counts! Join us in shaping a more inclusive & welcoming #IASLC community! Share your feedback on the global survey on inclusivity, where every voice counts. Take the survey & be the change you wish to see! https://t.co/WSlXh0bNPD https://t.co/q1eUZ0pai5